Scarica l'app Stockscreener
10.59
3.73%
-0.41
Dopo l'orario di chiusura:
10.40
-0.19
-1.79%
Enfusion Inc Borsa (ENFN) Ultime notizie
Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration - 01net
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc.ENFN - Business Wire
Learn to Evaluate (ENFN) using the Charts - news.stocktradersdaily.com
Shareholder Rights Advocates at Levi & Korsinsky Investigate Enfusion, Inc. (ENFN) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Lost Money on Enfusion, Inc. (ENFN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Bank of New York Mellon Corp Increases Stock Holdings in Enfusion, Inc. (NYSE:ENFN) - Defense World
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid - MSN
(ENFN) Trading Report - Stock Traders Daily
Enfusion, Inc. Reports Strong Growth Amid Acquisition Plans - MSN
Enfusion (ENFN) to Release Earnings on Tuesday - Defense World
Enfusion CEO Oleg Movchan sells $130,472 in stock By Investing.com - Investing.com South Africa
Rhumbline Advisers Has $643,000 Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World
Enfusion’s chief people officer sells shares worth $35,558 - Investing.com India
Enfusion CFO sells $52,836 in stock to cover tax obligations By Investing.com - Investing.com Canada
Enfusion Executives Cash In: Major Stock Sales Unveiled! - TipRanks
Enfusion chief accounting officer sells $6,165 in stock By Investing.com - Investing.com Canada
Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock - Investing.com
Enfusion chief accounting officer sells $6,165 in stock - Investing.com
Enfusion COO Neal Pawar sells $165,620 in stock - Investing.com
Enfusion’s chief people officer sells shares worth $35,558 By Investing.com - Investing.com South Africa
Enfusion Executives Sell Shares to Cover Tax Obligations - TradingView
Enfusion’s Hold Rating: Balancing Strategic Merger Benefits with Market Uncertainties - TipRanks
Enfusion CEO Oleg Movchan sells $130,472 in stock - Investing.com
Enfusion’s CAO Makes a Noteworthy Stock Sale! - TipRanks
Enfusion’s general counsel sells $12,410 in stock to cover taxes By Investing.com - Investing.com South Africa
Enfusion CEO Oleg Movchan sells $32,031 in stock - Investing.com India
Enfusion Executives Unload Major Stock Holdings! - TipRanks
Enfusion COO Neal Pawar sells $31,790 in stock By Investing.com - Investing.com Canada
Enfusion chief accounting officer sells $2,514 in stock - Investing.com Australia
Enfusion chief accounting officer sells $2,514 in stock By Investing.com - Investing.com South Africa
Enfusion CEO Oleg Movchan sells $32,031 in stock By Investing.com - Investing.com Canada
Enfusion CFO Bradley Herring sells $17,600 in stock By Investing.com - Investing.com South Africa
Enfusion COO Neal Pawar sells $31,790 in stock - Investing.com India
Enfusion’s chief people officer sells shares worth $23,696 - Investing.com India
Enfusion’s chief people officer sells shares worth $23,696 By Investing.com - Investing.com South Africa
Stifel maintains Enfusion stock Hold rating, $11.25 target By Investing.com - Investing.com Canada
Stifel maintains Enfusion stock Hold rating, $11.25 target - Investing.com India
Enfusion, Inc. (ENFN) Lags Q4 Earnings and Revenue Estimates - MSN
Enfusion earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Enfusion Q4 Adjusted Earnings Fall, Revenue Rises -March 03, 2025 at 05:38 pm EST - Marketscreener.com
Enfusion Announces Fourth Quarter and Full Year 2024 Results - TradingView
4.01%
6.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):